Sundrug Co (SDGCF) Stock Statistics & Valuation Metrics
Total Valuation
Sundrug Co has a market cap or net worth of $2.68B. The enterprise value is $431.73B.
- Market Cap
- $2.68B
- Enterprise Value
- $431.73B
Share Statistics
Sundrug Co has 119,331,184 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 119,331,184
- Owned by Insiders
- ―
- Owned by Institutions
- 9.70%
Financial Efficiency
Sundrug Co’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 9.23%.
- Return on Equity (ROE)
- 0.11
- Return on Assets (ROA)
- 0.07
- Return on Invested Capital (ROIC)
- 9.23%
- Return on Capital Employed (ROCE)
- 0.14
- Revenue Per Employee
- 112.98M
- Profits Per Employee
- 4.21M
- Employee Count
- 7,457
- Asset Turnover
- 1.77
- Inventory Turnover
- 5.85
Valuation Ratios
The current PE Ratio of Sundrug Co is 13.44. Sundrug Co’s PEG ratio is 75.20.
- PE Ratio
- 13.44
- PS Ratio
- 0.50
- PB Ratio
- 1.48
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- 75.20
Income Statement
In the last 12 months, Sundrug Co had revenue of 842.51B and earned 31.39B in profits. Earnings per share was 268.36.
- Revenue
- 842.51B
- Gross Profit
- 197.41B
- Operating Income
- 46.83B
- Pretax Income
- 45.80B
- Net Income
- 31.39B
- EBITDA
- 64.95B
- Earnings Per Share (EPS)
- 268.36
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Sundrug Co pays an annual dividend of $0.40, resulting in a dividend yield of 2.94%
- Dividend Per Share
- $0.40
- Dividend Yield
- 2.94%
- Payout Ratio
- 51.73%
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 7.44%
Stock Price Statistics
- Beta
- -0.03
- 52-Week Price Change
- -15.57%
- 50-Day Moving Average
- 22.94
- 200-Day Moving Average
- 23.67
- Relative Strength Index (RSI)
- 51.64
- Average Volume (3m)
- ―
Important Dates
Sundrug Co upcoming earnings date is Nov 13, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 14, 2026
- Next Earnings Date
- Nov 13, 2026
- Ex-Dividend Date
- Sep 29, 2026
Financial Position
Sundrug Co as a current ratio of 1.78, with Debt / Equity ratio of 16.86%
- Current Ratio
- 1.78
- Quick Ratio
- 0.95
- Debt to Market Cap
- 0.11
- Net Debt to EBITDA
- -0.34
- Interest Coverage Ratio
- 121.96
Taxes
In the past 12 months, Sundrug Co has paid 14.41B in taxes.
- Income Tax
- 14.41B
- Effective Tax Rate
- 0.31
Enterprise Valuation
Sundrug Co EV to EBITDA ratio is 6.28, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.48
- EV to EBITDA
- 6.28
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Sundrug Co has $61.35B in cash and marketable securities with $47.97B in debt, giving a net cash position of $13.39B billion.
- Cash & Marketable Securities
- $61.35B
- Total Debt
- $47.97B
- Net Cash
- $13.39B
- Net Cash Per Share
- $112.19
- Tangible Book Value Per Share
- $2,379.58
Margins
Gross margin is 25.08%, with operating margin of 4.90%, and net profit margin of 3.70%.
- Gross Margin
- 25.08%
- Operating Margin
- 4.90%
- Pretax Margin
- 5.37%
- Net Profit Margin
- 3.70%
- EBITDA Margin
- 7.67%
- EBIT Margin
- 5.42%
Analyst Forecast
The average price target for Sundrug Co is $26.84, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $26.84
- Price Target Upside
- 16.97% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- 1.10%
- EPS Growth Forecast
- -2.90%